Biotech Values

[ghmm]

NKTR:

Nektar Therapeutics Announces Public Offering of Shares of Common Stock


My guess is Howard was seeing partnership interest in 214 and when he didn't get terms he liked did the BMY collaboration and this was the long awaited financing (at least by me) since there was no partnership. Lets see if it works out better this time. Around the time I bought my first shares (before initiating P3) he had all but said NKTR-102 was about to be partnered but it would seem a deal fell through which resulted in them pushing it on their own (a move I wasn't a fan of).

http://finance.yahoo.com/news/nektar-therapeutics-announces-public-offering-200100922.html

SAN FRANCISCO, Oct. 17, 2016 /PRNewswire/ -- Nektar Therapeutics (NKTR) ("Nektar") today announced that it has commenced an underwritten public offering of $175 million of shares of its common stock. In connection with this offering, Nektar will also grant to the underwriters a 30-day option to purchase up to an additional $26.25 million of shares of common stock. J.P. Morgan is acting as the sole book-running manager in the offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Nektar intends to use the net proceeds from this offering for general corporate purposes including research and development funding and working capital.